127 related articles for article (PubMed ID: 9364868)
41. Sweet's syndrome associated with granulocyte colony-stimulating factor.
Hasegawa M; Sato S; Nakada M; Nitta H; Shirasaki H; Kasahara K; Takehara K
Eur J Dermatol; 1998; 8(7):503-5. PubMed ID: 9854164
[TBL] [Abstract][Full Text] [Related]
42. [Chemotherapy schedules and bacteremia in adult patients with acute leukemia].
Brodsky AL; Melero MJ; Minissale CJ; Sánchez Avalos JC
Medicina (B Aires); 1996; 56(4):327-32. PubMed ID: 9138335
[TBL] [Abstract][Full Text] [Related]
43. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
[TBL] [Abstract][Full Text] [Related]
44. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
45. [Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts].
Hagiwara S; Yuo A; Nagai M; Takezako N; Soda Y; Miwa A; Togawa A; Takaku F
Rinsho Ketsueki; 1996 Nov; 37(11):1259-64. PubMed ID: 8960658
[TBL] [Abstract][Full Text] [Related]
46. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
[TBL] [Abstract][Full Text] [Related]
47. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
48. [Improvement of thrombocytopenia by administration of M-CSF in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia].
Endo A; Tajima F; Kawatani T; Kawasaki H
Rinsho Ketsueki; 1996 Sep; 37(9):863-6. PubMed ID: 8914477
[TBL] [Abstract][Full Text] [Related]
49. Successful treatment of childhood hypocellular acute myeloid leukemia.
Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Iesato K; Nakanishi K; Noguchi H; Miyachi H; Ito M; Tsutsumi H; Suzuki N
J Pediatr Hematol Oncol; 2012 Jul; 34(5):398-401. PubMed ID: 22278198
[TBL] [Abstract][Full Text] [Related]
50. [Acute myeloid leukemia (M1) following chemotherapy for Ki-1 lymphoma complicated with rheumatoid arthritis].
Yoshida K; Endoh K; Itoh Y; Kawai N; Matsuda A; Murohashi I; Jinnai I; Ino H; Bessho M; Takeuchi H
Rinsho Ketsueki; 1995 Dec; 36(12):1365-71. PubMed ID: 8587173
[TBL] [Abstract][Full Text] [Related]
51. [Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide].
Kikuta T; Shimazaki C; Hirai H; Sumikuma T; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Fujita N; Hatta T; Nakagawa M
Rinsho Ketsueki; 1996 Nov; 37(11):1276-82. PubMed ID: 8960661
[TBL] [Abstract][Full Text] [Related]
52. [Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy].
Sanz Ortiz J; Llamazares A; López-Vega JM
Med Clin (Barc); 1993 Sep; 101(7):276. PubMed ID: 7538188
[No Abstract] [Full Text] [Related]
53. Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia.
Zhang X; Guo X
Ann Hematol; 2019 Sep; 98(9):2223-2225. PubMed ID: 30980106
[No Abstract] [Full Text] [Related]
54. Acceleration of leukaemia with granulocyte colony-stimulating factor in a patient with aleukaemic leukaemia.
Fata F; Myers P; Addeo J; Nawabi I
Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):111-2. PubMed ID: 9349378
[No Abstract] [Full Text] [Related]
55. A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.
Uy GL; Rettig MP; Stone RM; Konopleva MY; Andreeff M; McFarland K; Shannon W; Fletcher TR; Reineck T; Eades W; Stockerl-Goldstein K; Abboud CN; Jacoby MA; Westervelt P; DiPersio JF
Blood Cancer J; 2017 Mar; 7(3):e542. PubMed ID: 28282031
[No Abstract] [Full Text] [Related]
56. [Hypoplastic leukemia successfully treated with low-dose aclarubicin: a case report].
Toyota E; Ohtsuki T; Kamiyama N; Fukushima T; Shirato L; Kanzaki A; Yamada O; Yawata Y
Rinsho Ketsueki; 1991 Sep; 32(9):996-1000. PubMed ID: 1942547
[TBL] [Abstract][Full Text] [Related]
57. [Acute basophilic leukemia: a case report].
Iehara K; Tashiro E; Ashihara E; Okawa K; Oku N; Goto H; Inaba T; Ito K; Fujita N; Shimazaki C
Rinsho Ketsueki; 1993 Jul; 34(7):847-52. PubMed ID: 7689662
[TBL] [Abstract][Full Text] [Related]
58. Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide.
Bohgaki T; Notoya A; Kondo M; Mukai M; Kohno M
Leuk Lymphoma; 2001 Jan; 40(3-4):433-6. PubMed ID: 11426568
[TBL] [Abstract][Full Text] [Related]
59. [Ischemic hepatitis due to anthracycline-induced cardiac insufficiency in a patient with acute myelocytic leukemia (M0)].
Toi T; Sawai H; Takeda Y; Mizuta K; Tashima M; Sawada H; Okuma M
Rinsho Ketsueki; 1995 Jan; 36(1):50-5. PubMed ID: 7715077
[TBL] [Abstract][Full Text] [Related]
60. Marked increase of peripheral blood myeloblasts following G-CSF therapy in a patient with acute lymphoblastic leukemia.
Hosokawa T; Tomoda T; Misaki Y; Wakiguchi H; Kurashige T
Acta Paediatr Jpn; 1995 Feb; 37(1):78-80. PubMed ID: 7538724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
